Huaiwei Yang1, Jingwei Liu1, Jingjing Jing1, Zeyang Wang1, Yi Li1, Kaihua Gou1, Xue Feng1, Yuan Yuan2, Chengzhong Xing3. 1. Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Affiliated Hospital of China Medical University, Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department, 155# North Nanjing Street, Heping District, Shenyang City, 110001, Liaoning Province, China. 2. Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Affiliated Hospital of China Medical University, Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department, 155# North Nanjing Street, Heping District, Shenyang City, 110001, Liaoning Province, China. yuanyuan@cmu.edu.cn. 3. Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Affiliated Hospital of China Medical University, Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department, 155# North Nanjing Street, Heping District, Shenyang City, 110001, Liaoning Province, China. xcz1966@126.com.
Abstract
BACKGROUND: Damage-specific DNA binding protein 2 (DDB2) is implicated in the recognition of DNA damage and the initiation of nucleotide excision repair process. The aim of this study was to explore the role of DDB2 in the initiation, progression, and prognosis of colorectal cancer (CRC). METHODS: Totally tissues of 300 CRC and 300 adjacent, 267 colorectal adenoma (CRA) and 214 normal (NOR) were collected. The expression of DDB2 protein was detected by immunohistochemical staining. RESULTS: DDB2 protein was highly expressed in CRC and CRA compared with NOR (P < 0.001, respectively) in the dynamic sequence of NOR → CRA → CRC; CRC tissue demonstrated increased DDB2 expression compared with non-tumor adjacent tissues (P < 0.001). DDB2 expression was higher in T1-T2 than that in T3-T4 in CRC (P = 0.023); cloddy/nested CRC demonstrated increased DDB2 expression than infiltrative CRC (P = 0.007). Survival analysis showed that high DDB2 expression was associated with favorable survival in colon cancer (adjusted HR 0.20, 95% CI 0.06-0.72, P = 0.014) and female CRC patients (adjusted HR 0.27, 95% CI 0.08-0.92, P = 0.036). CONCLUSION: DDB2 protein expression was associated with the initiation, progression, and prognosis of CRC, and might function as a tumor biomarker for the diagnosis and prognosis of CRC.
BACKGROUND:Damage-specific DNA binding protein 2 (DDB2) is implicated in the recognition of DNA damage and the initiation of nucleotide excision repair process. The aim of this study was to explore the role of DDB2 in the initiation, progression, and prognosis of colorectal cancer (CRC). METHODS: Totally tissues of 300 CRC and 300 adjacent, 267 colorectal adenoma (CRA) and 214 normal (NOR) were collected. The expression of DDB2 protein was detected by immunohistochemical staining. RESULTS:DDB2 protein was highly expressed in CRC and CRA compared with NOR (P < 0.001, respectively) in the dynamic sequence of NOR → CRA → CRC; CRC tissue demonstrated increased DDB2 expression compared with non-tumor adjacent tissues (P < 0.001). DDB2 expression was higher in T1-T2 than that in T3-T4 in CRC (P = 0.023); cloddy/nested CRC demonstrated increased DDB2 expression than infiltrative CRC (P = 0.007). Survival analysis showed that high DDB2 expression was associated with favorable survival in colon cancer (adjusted HR 0.20, 95% CI 0.06-0.72, P = 0.014) and female CRC patients (adjusted HR 0.27, 95% CI 0.08-0.92, P = 0.036). CONCLUSION:DDB2 protein expression was associated with the initiation, progression, and prognosis of CRC, and might function as a tumor biomarker for the diagnosis and prognosis of CRC.
Authors: Sergey Alekseev; Hanneke Kool; Heggert Rebel; Maria Fousteri; Jill Moser; Claude Backendorf; Frank R de Gruijl; Harry Vrieling; Leon H F Mullenders Journal: Cancer Res Date: 2005-11-15 Impact factor: 12.701
Authors: Gabriela Vilas Bôas Gomez; Cristiane de Oliveira; José Augusto Rinck-Junior; Aparecida Machado de Moraes; Gustavo Jacob Lourenço; Carmen Silvia Passos Lima Journal: Tumour Biol Date: 2015-10-02
Authors: Marie Ennen; Rémi Klotz; Nadège Touche; Sophie Pinel; Claire Barbieux; Vanessa Besancenot; Emilie Brunner; Denise Thiebaut; Alain C Jung; Sonia Ledrappier; Lionel Domenjoud; Joseph Abecassis; François Plénat; Stéphanie Grandemange; Philippe Becuwe Journal: Cancer Res Date: 2013-06-17 Impact factor: 12.701
Authors: Jae Joon Han; Sun Kyung Baek; Jae Jin Lee; Gou Young Kim; Si-Young Kim; Suk-Hwan Lee Journal: Cancer Res Treat Date: 2014-01-15 Impact factor: 4.679